NCT04777175
A Retrospective Study: Evaluation of the Efficacy of Immunotherapy With Rare Mutations in Non-small Cell Lung Cancer
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 4 with changes below, 1 re-verified with no change.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
- Notable Primary completion date: Jan 1, 2024 to Jan 1, 2025v5
- Notable Primary completion date: Jan 1, 2023 to Jan 1, 2024
- Start date: Jan 1, 2021 to Jan 1, 2023
- Study completion date: Jan 12, 2023 to Jan 12, 2025
- Notable Primary completion date: Jan 1, 2022 to Jan 1, 2023
- Study completion date: Jan 1, 2023 to Jan 12, 2023
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
PFS
Timeframe: January 2021- January 2021 (1 year)
Arms and interventions
KRAS mutation
patients carry with KRAS mutation
ALK fusion
patients carry with ALK fusion
ERBB2 mutation
patients carry with ERBB2 mutation
MET skipping/amplication
patients carry with MET skipping/amplication
RET fusion
patients carry with RET fusion
BRAF mutation
patients carry with BRAF mutation
Drugs: immunity therapy
Sites
2 sites in 1 country